North Carolina macular dystrophy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

North Carolina macular dystrophy
Synonyms	MCDR1, NCMD
Pronounce
Specialty	Ophthalmology
Symptoms	Macular degeneration, vision loss
Complications	N/A
Onset	Childhood
Duration	Lifelong
Types
Causes	Genetic mutation
Risks
Diagnosis	Ophthalmic examination, genetic testing
Differential diagnosis	Age-related macular degeneration, Stargardt disease
Prevention
Treatment	Low vision aids, supportive care
Medication
Prognosis	Variable, generally stable
Frequency	Rare
Deaths

North Carolina Macular Dystrophy (NCMD), also known as MCDR1, is a rare genetic disorder characterized by the development of macular degeneration at birth or in early childhood, leading to varying degrees of visual impairment. This condition is notable for its autosomal dominant inheritance pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. NCMD is specifically associated with mutations in the PRDM13 gene located on chromosome 6, although the exact mechanism by which these mutations lead to the symptoms of the disease is not fully understood.

Symptoms and Diagnosis

The primary symptom of North Carolina Macular Dystrophy is visual impairment, which ranges from mild to severe and is usually present from birth or develops in early childhood. The disease is characterized by the presence of drusen-like deposits and atrophic changes in the macula, the part of the retina responsible for sharp, central vision. Unlike age-related macular degeneration, NCMD symptoms typically do not progress significantly over time. Diagnosis of NCMD is primarily based on clinical examination, including the use of ophthalmoscopy to observe the characteristic macular lesions. Genetic testing can confirm the diagnosis by identifying mutations in the PRDM13 gene.

Treatment and Management

There is currently no cure for North Carolina Macular Dystrophy. Treatment focuses on managing symptoms and supporting individuals with the condition to achieve their maximum potential vision. This may include the use of low vision aids and adaptive technologies to help affected individuals cope with their visual impairments. Regular monitoring by an ophthalmologist is recommended to address any changes in vision and associated conditions.

Epidemiology

North Carolina Macular Dystrophy is a rare condition, with a higher prevalence reported in individuals of European descent. The disorder was first identified in a large family from North Carolina, which is how it received its name. However, cases have been reported worldwide, indicating that NCMD is not limited to any specific geographic region or ethnic group.

Genetics

The condition is caused by mutations in the PRDM13 gene, which plays a role in eye development. The inheritance pattern of NCMD is autosomal dominant, meaning that an individual only needs one copy of the mutated gene from one parent to be affected. There is a 50% chance of passing the condition on to offspring if one parent carries the mutation.

Research

Research into North Carolina Macular Dystrophy is ongoing, with studies focusing on understanding the underlying genetic mechanisms and finding effective treatments. Advances in gene therapy and regenerative medicine offer hope for future interventions that could potentially restore vision or halt the progression of the disease.

   This article is a medical stub. You can help WikiMD by expanding it!